
CRISPR Therapeutics tokenized stock pricerCRSP
rCRSP/USD price calculator
In-depth analysis of CRISPR Therapeutics's market trends today
CRISPR Therapeutics market summary
The current price of CRISPR Therapeutics (rCRSP) is $53.4, with a 24-hour change of -0.67%. The current market capitalization is approximately --, and the 24-hour trading volume is $0.00.
CRISPR Therapeutics Key Takeaways
Based on real-time chart analysis, the current technical structure for CRISPR Therapeutics (rCRSP) shows a key support level at $52.00 and a primary resistance level at $55.00. A decisive move outside of this range could trigger a new trending phase for the stock. Overall, the market is currently in a sideways consolidation with a bullish bias phase, as the price stabilizes after recent gains while testing upper resistance zones.
Technical Indicators
RSI: The current RSI is approximately 59.45, indicating that market momentum is neutral to slightly bullish, moving away from previous oversold conditions but not yet in extreme overbought territory.
MACD: The signal is bullish, with the MACD line recently turning positive and a bullish crossover occurring in early August, suggesting increasing upward pressure.
MA: The MA structure is positive; the price is currently trading above the 50-day moving average ($52.24) and the 20-day moving average ($49.52), showing a strong short-to-medium term bullish trend.
Market Drivers
Current CRISPR Therapeutics price action and market sentiment are primarily driven by the following factors:
• CASGEVY Revenue Growth: Strong financial results for Q2 2026, with CASGEVY generating $76 million in revenue, representing 151% year-over-year growth, bolstered by recent FDA approval for children as young as 2 years old.
• Clinical Pipeline Expansion: Positive sentiment following the initiation of Phase 1 trials for CTX340 (hypertension) and CTX460 (AATD), alongside upcoming durability data for CTX310 at the ESC Congress 2026.
• Regulatory Momentum: Completed regulatory submissions in the Kingdom of Saudi Arabia and the United Kingdom for pediatric indications, expanding the addressable market for the company’s lead gene therapy.
Trading Signals
Based on current technical structures and market momentum, the following trading strategies are provided for reference:
Potential Buy Zone
• If the CRISPR Therapeutics price approaches the $52.00 - $52.80 support zone and shows signs of a bounce, it may present a short-term buying opportunity.
• If the price breaks above the $55.00 resistance level with a significant increase in trading volume, it would likely confirm a continuation of the upward trend.
Risk Scenario
• If the price falls and closes below the $52.00 support level, the market may enter a short-term correction phase, potentially retesting the $49.50 area.
Buy Strategy
Based on the current market structure, the following strategies are suggested:
Conservative Investors
• Wait for a price pullback to the $52.00 support level to build positions in stages.
• Alternatively, wait for a confirmed breakout and hold above the $55.00 resistance before entering.
Trend Investors
• If the price breaks the $55.00 resistance, a new bullish leg could form. The next target price is estimated at $58.10.
Long-term Investors
• As long as the price remains above the $52.00 key structural support, the medium-to-long term outlook remains constructive, supported by strong revenue growth and pipeline milestones.
Trends Summary
Market Insights
From a short-term perspective, CRISPR Therapeutics has displayed a steadily rising price structure over the past 7 days, with market sentiment turning optimistic following the Q2 earnings report. Medium-term analysis shows the price fluctuating within the $52.00 to $55.00 range as it attempts to break out of a longer-term horizontal channel.
Market Outlook
• If the price successfully breaks $55.00, the next target level is $58.10, followed by $61.20.
• If the price fails to hold $52.00, the next downside target is $49.50.
Market Consensus
The consensus among analysts is that while CRISPR Therapeutics may experience short-term consolidation near resistance, the medium-term trend remains bullish as long as the price stays above the $52.00 support level, driven by the commercial success of CASGEVY and clinical trial progress.
Now that you understand the market, it's time to start trading. CRISPR Therapeutics (rCRSP) is actively traded on Bitget Exchange, one of the world's largest cryptocurrency platforms with over 120 million registered users. Bitget offers spot trading for rCRSP/USDT with highly competitive fees, as low as 0% for makers and 0.03% for takers. The platform supports more than 1300 cryptocurrencies including CRISPR Therapeutics, maintains a protection fund exceeding $300 million, and provides 24/7 trading with deep liquidity. Bitget consistently ranks among the top exchanges by rCRSP trading volume.
Sign up for a free Bitget account and start trading now!Risk disclaimer
The above analysis is based on Bitget's real-time chart data and technical indicators, compiled and reviewed by the Bitget research team. It is for reference only and does not constitute investment advice. Cryptocurrency prices are highly volatile. Please make investment decisions based on your own risk tolerance.

GetAgent: Your AI for smarter trading decisions
CRISPR Therapeutics market info
Live CRISPR Therapeutics price today in USD
Do you think the price of CRISPR Therapeutics will rise or fall today?
Now that you know the price of CRISPR Therapeutics today, here's what else you can explore:
How to buy CRISPR Therapeutics (rCRSP)?How to sell CRISPR Therapeutics (rCRSP)?What is CRISPR Therapeutics (rCRSP)What would have happened if you had bought CRISPR Therapeutics (rCRSP)?What is the CRISPR Therapeutics (rCRSP) price prediction for this year, 2030, and 2050?Where can I download CRISPR Therapeutics (rCRSP) historical price data?What are the prices of similar cryptocurrencies today?Want to get cryptocurrencies instantly?
Buy cryptocurrencies directly with a credit card.Trade various cryptocurrencies on the spot platform for arbitrage.CRISPR Therapeutics price prediction
What will the price of rCRSP be in 2027?
In 2027, based on a +5% annual growth rate forecast, the price of CRISPR Therapeutics(rCRSP) is expected to reach $57.58; based on the predicted price for this year, the cumulative return on investment of investing and holding CRISPR Therapeutics until the end of 2027 will reach +5%. For more details, check out the CRISPR Therapeutics price predictions for 2026, 2027, 2030-2050.What will the price of rCRSP be in 2030?
You can trade rCRSP on Bitget
Hot stock assets trading on Bitget
Detailed introduction to Bitget rToken (rCRSP)
In short, rCRSP is a tokenized stock issued by licensed issuer Reality, pegged 1:1 to real CRISPR Therapeutics stock. It supports 24/7 trading, fractional shares, and dividends, and can be used as margin for the platform's unified trading account and USDT-M futures.
Buy rCRSPHow Bitget rToken (rCRSP) works
During U.S. market hours—including the regular session, pre-market, after-hours, and overnight sessions—spot orders for rCRSP are routed directly through a broker to the Nasdaq or NYSE order book. Once the trade is executed on the U.S. stock market, the execution result is reflected in the on-exchange spot order record. Any order you place for rCRSP while the U.S. market is open will also appear on the Nasdaq or NYSE order book. This means that during U.S. market hours, the trading price and liquidity of rCRSP are exactly the same as those of the underlying stock. Orders for rCRSP and their execution results are part of the U.S. stock market. There is no spread or so-called de-pegging, because rCRSP trades are executed directly on the U.S. stock market itself. The execution price you see for rCRSP is identical to the stock's price at that exact moment.
This makes rCRSP fundamentally different from traditional RWA tokens. The price of a traditional RWA asset is determined by on-chain liquidity and trading activity, whereas the price of rCRSP is directly equivalent to the stock price—it does not rely on any other mechanism to peg the asset's price. In terms of trading outcomes, trading rCRSP is no different from trading the stock directly.
Buy rCRSP with crypto assets on Bitget for the best stock trading experience
Bitget's spot trading market has listed over 500 rTokens (including rCRSP), offering native U.S. stock liquidity 24/5, with some trading pairs supporting 24/7 trading.
Market liquidity: The only tokenized stock that aligns with the market price and liquidity of major U.S. stock exchanges such as Nasdaq and the NYSE.
Maximum capital efficiency: rTokens can be used within the unified ecosystem for margin, Crypto Loans, Earn, and more, expanding the ways your assets can be used.
More flexible trading: Supports stablecoin deposits, T+0 fund turnover, 24/5 trading, with some pairs supporting 24/7 trading.
Fund security: The only RWA asset in the industry subject to daily third-party Proof of Reserves (PoR) audits, ensuring transparent asset reserves and protecting user funds.
Dividend rights: Eligible dividends are paid out to users' accounts in USDT.
Hold rCRSP and enjoy corporate actions aligned with the underlying stock
Corporate actions involving rCRSP (including dividend payments, stock splits, and reverse splits) are handled in the same way that a traditional broker would handle a stock position.
While holding rCRSP, whenever CRISPR Therapeutics stock pays a USD dividend, Reality automatically converts it into an equivalent amount of stablecoin (USDT) and distributes it 1:1 to the Bitget accounts of rCRSP holders. As a result, holding rCRSP entitles you to the same dividend rights as holding the actual stock, with the entire process handled automatically by the platform, requiring no manual action. It should be noted that dividends are subject to a flat 30% withholding tax applied by the U.S. to foreign investors. For users holding high-dividend assets (such as certain tech stocks or ETF-linked tokens), this means they can earn steady passive income on top of capital appreciation, further boosting the overall return on their holdings.
The issuer of rCRSP is based in El Salvador. Therefore, the withholding tax applicable to rCRSP follows the U.S. withholding tax rules for El Salvador.
Hold rCRSP and enjoy the flexibility of a crypto asset
Whether you're using a traditional broker or another platform, deposits and withdrawals are rarely a seamless experience. Traditional brokers may take time to process deposits. After a stock is sold, withdrawals typically take one to two days to process, and the funds may take even longer to arrive. Securities holdings also cannot be split, transferred, or reallocated. By contrast, rCRSP offers far greater flexibility than traditional stocks.
1. rCRSP can be sold on the exchange, and the proceeds are immediately available for transfer, with no T+1 restriction.
2. rCRSP can be freely transferred, withdrawn, or moved between sub-accounts, offering great flexibility and convenience. rCRSP is essentially a regular crypto asset, with no difference in use from Bitcoin.
3. rCRSP can be used directly as margin in a unified trading account to open futures positions. This allows users to participate in derivatives trading without selling their stock holdings, improving capital efficiency.
4. rCRSP can be used as collateral to borrow crypto assets such as USDT, USDC, and BTC on the platform for further trading or to purchase other rToken assets. This is similar to the margin lending services offered by traditional brokers and helps improve capital efficiency.
Understanding the risks
The advantage of rCRSP is that its price is exactly the same as the underlying stock's while also benefiting from the stock's deep liquidity. Even for less actively traded stocks, institutions don't need to worry about unexpected liquidations caused by price spikes resulting from insufficient on-exchange liquidity, as can happen with traditional tokens.
During weekends, when the U.S. stock market is closed, rCRSP continues to function as collateral without interruption. Even though rCRSP remains tradable over the weekend, its collateral value continues to be based on the last price before the U.S. market closes on Friday. This fixed index price is used for risk calculations, helping maintain a relatively stable collateral value and liquidation risk profile.
Why choose Bitget rToken? What are the main advantages of Bitget rToken over traditional stock investing?
Buy rCRSP nowWhere is the best place to buy crypto like CRISPR Therapeutics (rCRSP)?
rCRSP/USD price calculator
rCRSP resources
What can you do with cryptos like CRISPR Therapeutics (rCRSP)?
Deposit easily and withdraw quicklyBuy to grow, sell to profitTrade spot for arbitrageTrade futures for high risk and high returnEarn passive income with stable interest ratesTransfer assets with your Web3 walletHow do I buy CRISPR Therapeutics?
Learn how to get your first CRISPR Therapeutics in minutes.
1. Create a free Bitget account.
2. Select a funding method.
3. Buy your target crypto.
How do I sell CRISPR Therapeutics?
Learn how to cash out your CRISPR Therapeutics in minutes.
1. Create a free Bitget account.
2. Deposit crypto into your Bitget account.
3. Exchange your assets for fiat on the P2P market or for USDT on the spot market.